Didanosine Delayed Release Capsules

Didanosine Delayed Release Capsules are an antiretroviral medication used in combination therapy for the treatment of human immunodeficiency virus (HIV) infection. Didanosine belongs to the nucleoside reverse transcriptase inhibitor (NRTI) class and works by interfering with viral DNA replication, helping to slow the spread of HIV in the body.

The delayed-release formulation allows for controlled absorption, improving patient convenience and supporting consistent drug levels in the bloodstream. Didanosine Delayed Release Capsules are commonly prescribed as part of combination antiretroviral therapy (ART) to help reduce viral load and improve immune function when taken exactly as directed by a healthcare professional.

Didanosine delayed-release capsules follow strict pharmaceutical quality standards to ensure safety and reliability. This pharmaceutical product is widely supplied to hospitals, clinics, and healthcare institutions and plays an important role in long-term HIV treatment and management programs.

Product Features

• Contains Didanosine as the active antiretroviral ingredient
• Delayed-release capsule for controlled drug absorption
• It belongs to the NRTI class of HIV medicines
• Used as part of a combination antiretroviral therapy (ART)
• Meets established pharmaceutical quality standards

How It Helps

• Inhibits HIV reverse transcriptase enzyme activity
• Helps reduce HIV viral load in the bloodstream
• Supports improvement of immune system function
• Slows the progression of HIV infection
• Enhances the effectiveness of combination HIV treatment regimens